Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in targeted therapy of cholangiocarcinoma
Yuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Biliary stents for active materials and surface modification: Recent advances and future perspectives
Y. J. Li, Kunshan Yuan, Chengchen Deng, et al.
Bioactive Materials (2024) Vol. 42, pp. 587-612
Closed Access | Times Cited: 5
Significant Response to Palbociclib Plus Lenvatinib as Second-line Treatment for CDKN2A/2B Deletion Intrahepatic Cholangiocarcinoma: A Case Report
Kai Liu, Ziyue Huang, Lijin Zhao, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-κB signaling pathway
Shuo Zhou, Yuhang Yang, Feiyu Qi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma
Ling‐Yu Tang, Yuting Wang, Yongzhen Chen, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-13
Closed Access
Construction and validation of a diagnostic model for cholangiocarcinoma based on tumor-educated platelet RNA expression profiles
Haiyang Hu, Jiefeng He, Haoliang Zhao
ONCOLOGIE (2025)
Closed Access
Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions
GuanBo Zhang, Jinsong Li, Gang Li, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Strategies to enhance the response of liver cancer to pharmacological treatments
José J.G. Marı́n, Rocı́o I.R. Macı́as, Maitane Asensio, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C11-C33
Closed Access | Times Cited: 1
Percutaneous liver-directed therapies of intrahepatic cholangiocarcinoma
Brian Morse, Melissa McGettigan, Béla Kis
Abdominal Radiology (2024) Vol. 49, Iss. 12, pp. 4257-4263
Closed Access
Editorial: Clinical management of cholangiocarcinoma: surgical approaches and therapies
Hideo Takahashi, Noah Cohen, Kazunari Sasaki, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Image-Guided Ablation for Cholangiocarcinoma: Current Evidence and Future Directions
Jéssica Albuquerque Marques Silva, Iwan Paolucci, Kristy K. Brock, et al.
Digestive Disease Interventions (2024) Vol. 08, Iss. 04, pp. 263-271
Closed Access
New Relevant Evidence in Cholangiocarcinoma Biology and Characterization
N. M. Porro, Elena Spínola-Lasso, Mirella Pastore, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4239-4239
Open Access
Page 1

Scroll to top